Radulović et al., 2014 - Google Patents
Synthesis, spectral characterization, cytotoxicity and enzyme-inhibiting activity of new ferrocene–indole hybridsRadulović et al., 2014
View PDF- Document ID
- 5742596488886600261
- Author
- Radulović N
- Zlatković D
- Mitić K
- Randjelović P
- Stojanović N
- Publication year
- Publication venue
- Polyhedron
External Links
Snippet
Incorporation of a ferrocene moiety into the 2-phenylindole scaffold has been recently reported to drastically improve the cytotoxic activity of the parent compounds. In our search for new promising cytotoxic agents we designed and prepared two new ferrocene–indole …
- 230000002401 inhibitory effect 0 title abstract description 20
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Radulović et al. | Synthesis, spectral characterization, cytotoxicity and enzyme-inhibiting activity of new ferrocene–indole hybrids | |
| Rao et al. | 3-Substitued indoles: one-pot synthesis and evaluation of anticancer and Src kinase inhibitory activities | |
| Imran et al. | Synthesis, biological evaluation, and docking studies of novel thiourea derivatives of bisindolylmethane as carbonic anhydrase II inhibitor | |
| Gao et al. | Synthesis and anticancer activity of some novel 2-phenazinamine derivatives | |
| KR20170081213A (en) | Ezh2 inhibitors and uses thereof | |
| Hu et al. | Synthesis and biological evaluation of 1-(2-(adamantane-1-yl)-1 H-indol-5-yl)-3-substituted urea/thiourea derivatives as anticancer agents | |
| Denya et al. | Design, synthesis and evaluation of indole derivatives as multifunctional agents against Alzheimer's disease | |
| Mattarei et al. | A mitochondriotropic derivative of quercetin: a strategy to increase the effectiveness of polyphenols | |
| Thakur et al. | Novel 3, 5-bis (arylidiene)-4-piperidone based monocarbonyl analogs of curcumin: anticancer activity evaluation and mode of action study | |
| Basiri et al. | Microwave assisted synthesis, cholinesterase enzymes inhibitory activities and molecular docking studies of new pyridopyrimidine derivatives | |
| WO2007084162A2 (en) | Sirtuin inhibiting compounds | |
| Samadi et al. | Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles | |
| Wang et al. | A novel ferulic acid derivative attenuates myocardial cell hypoxia reoxygenation injury through a succinate dehydrogenase dependent antioxidant mechanism | |
| WO2014023329A1 (en) | Niclosamide and its derivatives for use in the treatment of solid tumors | |
| WO2024008129A1 (en) | Compound as kat6 inhibitor | |
| DE69734246T2 (en) | SYSNTHESIS PROCESS FOR THE PREPARATION OF INDOLYLQUINONES AND MONO AND BIS INDOLYLQUINONE PRODUCED BY THE METHOD | |
| Szulawska‐Mroczek et al. | Synthesis and biological evaluation of new bischromone derivatives with antiproliferative activity | |
| Arsenyan et al. | 4-Methyl-1, 2, 3-selenadiazole-5-carboxylic acid amides: antitumor action and cytotoxic effect correlation | |
| CN111918864A (en) | Prodrug compounds activated by AKR1C3 and their use to treat hyperproliferative disorders | |
| Kaplancıklı et al. | Synthesis and antiproliferative activity of new 1, 5-disubstituted tetrazoles bearing hydrazone moiety | |
| CN110156822B (en) | Naphthol-phenylboronic acid compound and preparation method and application thereof | |
| KR20170129688A (en) | Compounds containing core structure of indole acetic acid and uses thereof | |
| RU2697409C1 (en) | 1-adamantyl-3-(((1r,4as,10ar)-7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl)methyl)urea, which exhibits inhibiting action on human tyrosyl-dna-phosphodiesterase 1 enzyme and increases activity of temozolomide against glioblastoma cells | |
| Tercel et al. | Preparation and Antitumour Properties of the Enantiomers of a Hypoxia‐Selective Nitro Analogue of the Duocarmycins | |
| Baartzes et al. | Synthesis, characterization and antimicrobial evaluation of mono-and polynuclear ferrocenyl-derived amino and imino complexes |